Amplia Therapeutics Limited announced that Mr. Tim Luscombe will replace Mr. Hamish George as Chief Financial Officer (CFO) of the Company. Mr. Luscombe is a highly experienced Chartered Accountant who holds a Bachelor of Commerce from the University of Melbourne and a Certificate in Governance Practice from the Governance Institute of Australia. He is a Director at Bio101 Financial Advisory and has been working with Amplia in a senior accounting capacity over the last two years.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.057 AUD | -5.00% | -8.06% | -28.75% |
16/04 | Amplia Therapeutics to Raise AU$4.3 Million for Cancer Trials, Drug Capsule Manufacturing | MT |
27/03 | Amplia Concludes Phase I Trials of Anti-Cancer Drug; Prepares for Phase II | MT |
1st Jan change | Capi. | |
---|---|---|
-28.75% | 76.86L | |
+4.92% | 11TCr | |
+11.07% | 11TCr | |
-0.38% | 2.23TCr | |
-11.89% | 2.21TCr | |
-7.66% | 1.87TCr | |
-36.52% | 1.76TCr | |
-10.01% | 1.69TCr | |
+3.67% | 1.38TCr | |
+35.85% | 1.25TCr |
- Stock Market
- Equities
- ATX Stock
- News Amplia Therapeutics Limited
- Amplia Therapeutics Limited Announces Chief Financial Officer Changes